PATENT CLAIM ANALYSIS

Application Number: 16394610
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "394000"]

Abstract:
A drinkable pharmaceutical solution includes telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof, where the telmisartan has a concentration of 1 to 10 mg/ml within the drinkable pharmaceutical solution, and the drinkable pharmaceutical solution has a pH of 10.

Claim (Index 14):
A method of treating hypertension or kidney disease comprising administering a drinkable pharmaceutical solution to a cat, the pharmaceutical solution comprising:\n telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof, wherein telmisartan is at a concentration of 1 mg/ml to 10 mg/ml within the pharmaceutical solution, and the drinkable pharmaceutical solution has a pH of 10.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 100.0
- Lexical Diversity: 1.60714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14469750', '13321216', '13687820', '10570697', '14071740']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7524488347155782
- 35 USC 102 Novelty (BERT): 0.561359125496736
- Combined Prediction Score: 0.7333398637936941
- Mean Citation Score: 283.583444
- Max Citation Score: 436.93118
- Similarity Product: 384.6575181021452

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test